phosphatidylcholines has been researched along with alprenolol in 10 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (alprenolol) | Trials (alprenolol) | Recent Studies (post-2010) (alprenolol) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 1,146 | 121 | 59 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | alprenolol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.0031 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.007 | |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.63 | |
| Beta-3 adrenergic receptor | Homo sapiens (human) | 0.0023 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0049 | |
| Squalene synthase | Rattus norvegicus (Norway rat) | 4.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lopez, RA; Piotrowski, E; Sengupta, S; Slomiany, A; Slomiany, BL | 1 |
| Brown, LA; Chen, M | 1 |
| Jancinová, V; Nosál, R | 1 |
| Arnold, K; Barthel, D; Lange, K; Lenk, R; Zschoernig, O | 1 |
| Johnson, GL; Kelleher, DJ; Rashidbaigi, A; Ruoho, AE | 1 |
| Fain, JN; Mohell, N; Wallace, M | 1 |
| Caldwell, GW; Evangelisto, M; Masucci, JA; White, R | 1 |
| Devanathan, S; Kobilka, B; Salamon, Z; Tollin, G; Yao, Z | 1 |
| Ikonen, M; Kontturi, K; Murtomäki, L | 1 |
| Hoshino, T; Liu, X; Mahmood, I; Neya, S | 1 |
10 other study(ies) available for phosphatidylcholines and alprenolol
| Article | Year |
|---|---|
Role of adrenergic and cholinergic mediators in salivary phospholipids secretion.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Carbachol; Cells, Cultured; Cyclic AMP; Isoproterenol; Lysophosphatidylcholines; Male; Phorbol Esters; Phosphatidylcholines; Phospholipids; Pilocarpine; Rats; Rats, Inbred Strains; Saliva; Salivary Glands | 1992 |
Histamine stimulation of surfactant secretion from rat type II pneumocytes.
Topics: Adenylyl Cyclases; Alprenolol; Animals; Cells, Cultured; Cimetidine; Cyclic AMP; Histamine; Isoproterenol; Kinetics; Lung; Male; Phosphatidylcholines; Pulmonary Surfactants; Pyrilamine; Rats; Rats, Inbred Strains | 1990 |
Differences among beta-adrenoceptor blocking drugs in modifying platelet aggregation and arachidonic acid liberation under thrombin stimulation.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arachidonic Acid; Arachidonic Acids; Atenolol; Hydrolysis; Metipranolol; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Platelet Aggregation Inhibitors; Propranolol; Solubility; Thrombin | 1989 |
Interaction of electrically charged drug molecules with phospholipid membranes.
Topics: Alprenolol; Chlorpromazine; Electrophoresis; Liposomes; Membrane Lipids; Pharmaceutical Preparations; Phosphatidylcholines; Propanolamines; Propranolol; Solubility; Surface Properties; Tetracaine | 1988 |
Rapid vesicle reconstitution of alprenolol-Sepharose-purified beta 1-adrenergic receptors. Interaction of the purified receptor with N.
Topics: Adenylyl Cyclases; Alprenolol; Animals; Chromatography, Affinity; Deoxycholic Acid; Digitonin; Erythrocyte Membrane; GTP-Binding Proteins; Humans; Isoproterenol; Kinetics; Phosphatidylcholines; Receptors, Adrenergic, beta; Receptors, Cell Surface; Turkeys | 1983 |
Alpha 1-adrenergic stimulation of phosphatidylinositol turnover and respiration of brown fat cells.
Topics: Adipose Tissue, Brown; Alprenolol; Animals; Cricetinae; Glycerol; Kinetics; Male; Mesocricetus; Oxygen Consumption; Phenylephrine; Phosphates; Phosphatidylcholines; Phosphatidylinositols; Phosphorus Radioisotopes; Prazosin; Tritium; Yohimbine | 1984 |
Evaluation of the immobilized artificial membrane phosphatidylcholine. Drug discovery column for high-performance liquid chromatographic screening of drug-membrane interactions.
Topics: Acebutolol; Acetonitriles; Adrenergic beta-Antagonists; Alprenolol; Aniline Compounds; Atenolol; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Membranes, Artificial; Metoprolol; Models, Chemical; Osmolar Concentration; Oxprenolol; Phosphatidylcholines; Pindolol; Propranolol; Reproducibility of Results; Timolol | 1998 |
Plasmon-waveguide resonance studies of ligand binding to the human beta 2-adrenergic receptor.
Topics: Adrenergic Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Alprenolol; Anisotropy; Epinephrine; Humans; Isoproterenol; Kinetics; Ligands; Lipid Bilayers; Phosphatidylcholines; Propanolamines; Protein Binding; Proteolipids; Receptors, Adrenergic, beta-2; Spectrum Analysis; Surface Plasmon Resonance | 2004 |
Microcalorimetric and zeta potential study on binding of drugs on liposomes.
Topics: Algorithms; Alprenolol; Binding Sites; Binding, Competitive; Calorimetry; Entropy; Kinetics; Labetalol; Liposomes; Models, Chemical; Molecular Structure; Pharmaceutical Preparations; Phosphatidylcholines; Phosphatidylglycerols; Propranolol; Tetracaine; Thermodynamics | 2010 |
Influence of lipid composition on the structural stability of g-protein coupled receptor.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Alprenolol; Binding Sites; Cholesterol; Epinephrine; G(M1) Ganglioside; Hydrophobic and Hydrophilic Interactions; Lipid Bilayers; Molecular Dynamics Simulation; Phosphatidylcholines; Protein Binding; Protein Stability; Protein Structure, Tertiary; Receptors, Adrenergic, beta-2 | 2013 |